You just read:

Medimetriks Pharmaceuticals, Inc. Receives FDA Approval for Xepi™ (ozenoxacin) Cream, 1%, a Novel Topical Antibiotic for Impetigo

News provided by

Medimetriks Pharmaceuticals, Inc.

Dec 14, 2017, 07:18 EST